Endothelial cell loss 5 years after Preserflo MicroShunt implantation: About two cases

PURPOSE: Preserflo MicroShunt is a minimally-invasive glaucoma drainage micro-tube used to shunt aqueous humor from the anterior chamber to the subtenon space. The safety of the procedure was considered satisfactory with a majority of minor side effects. OBSERVATION: We describe the 5 year endotheli...

Descripción completa

Detalles Bibliográficos
Autores principales: Chamard, Chloé, Hammoud, Sirine, Bluwol, Elisa, Lachkar, Yves
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8683644/
https://www.ncbi.nlm.nih.gov/pubmed/34977424
http://dx.doi.org/10.1016/j.ajoc.2021.101238

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8683644/
https://www.ncbi.nlm.nih.gov/pubmed/34977424
http://dx.doi.org/10.1016/j.ajoc.2021.101238

Ejemplares similares